Featured Papers in Cardiovascular Medicine 2021
Submission Deadline: 1 Jan 2022
Guest Editor
Special Issue Information
Dear Colleagues,
The arterial pole is one of the most complex parts of the heart both in development and disease. Thus, Cardiovascular Medicine Research plays an increasingly important role in solving societal challenges such as Ventricular arrhythmias, Epidemiology and Lifestyle, in our understanding of molecular biology, and in the advance of medicine. The Special Issue "Feature Papers in Cardiovascular Medicine 2021" will collect high-quality original research papers and comprehensive reviews on recent advances in cardiovascular disease, vascular disease, heart failure and cardiac disease. The topic of interests include but are not limited to:
- Atherosclerotic cardiovascular disease
●Myocardial disease
● Valvular disorders
● Arrhythmias
● Cardiovascular Imagining
● Genetics
● Biomarkers
● Clinical decision making and real world outcomes
Manuscripts submitted to this Special Issue will be subjected to more stringent selection criteria to ensure the privileged position of accepted contributions. Those that fail to pass this selection will be considered for publication in RCM as regular contributions.
Prof. Dr. Peter A. McCullough, MD, MPH
Editor-in-Chief
Keywords
- Cardiovascular disease
- Cardiovascular Imagining
- Biomarkers
- Genetics
- Diagnostic testing
- Clinical decision
- Puality and outcomes
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (9)
Biomarkers of endothelial activation and dysfunction in cardiovascular diseases
Rev. Cardiovasc. Med. 2022, 23(2), 73; https://doi.org/10.31083/j.rcm2302073
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
Heart injuries related to cardiopulmonary resuscitation: a risk often overlooked
Rev. Cardiovasc. Med. 2022, 23(2), 61; https://doi.org/10.31083/j.rcm2302061
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
The role of 3D printed heart models in immediate and long-term knowledge acquisition in medical education
Rev. Cardiovasc. Med. 2022, 23(1), 22; https://doi.org/10.31083/j.rcm2301022
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
The association of procedural variables and lipid parameters with coronary rotational atherectomy outcomes
Rev. Cardiovasc. Med. 2021, 22(4), 1649–1656; https://doi.org/10.31083/j.rcm2204172
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study
Rev. Cardiovasc. Med. 2021, 22(4), 1577–1587; https://doi.org/10.31083/j.rcm2204163
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results
Rev. Cardiovasc. Med. 2021, 22(4), 1429–1449; https://doi.org/10.31083/j.rcm2204148
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
Clinical outcomes in patients with heart failure with and without cirrhosis: an analysis from the national inpatient sample
Rev. Cardiovasc. Med. 2021, 22(3), 925–929; https://doi.org/10.31083/j.rcm2203100
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease
Rev. Cardiovasc. Med. 2021, 22(3), 755–768; https://doi.org/10.31083/j.rcm2203082
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)
Cardionephrology and cardiorenal disease in Italy: state of the art
Rev. Cardiovasc. Med. 2021, 22(3), 563–572; https://doi.org/10.31083/j.rcm2203068
(This article belongs to the Special Issue Featured Papers in Cardiovascular Medicine 2021)